Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1622-1628

  Maudsdotter, Lisa ^a   Jonsson, Hans ^b   Roos, Stefan ^b   Jonsson, Ann Beth ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; LIPOTEICHOIC ACID; MEMBRANE COFACTOR PROTEIN; PROBIOTIC AGENT;

AMINO ACID SYNTHESIS; APOPTOSIS; ARTICLE; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIODEGRADATION; CELL DAMAGE; CELL DEATH; CELL PROTECTION; COLONY FORMING UNIT; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GROUP A STREPTOCOCCAL INFECTION; HOST CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LACTOBACILLUS; LACTOBACILLUS ORIS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NECROTIZING FASCIITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SECRETION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

CELL LINE; CELL SURVIVAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LACTIC ACID; LACTOBACILLUS; LIPOPOLYSACCHARIDES; STREPTOCOCCUS PYOGENES; TEICHOIC ACIDS;

EID: 79953212954     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00770-10     Document Type: Article

References (54)

1. Ahrne, S., et al. 1998. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85:88-94.
2. Andreadis, S. T., K. E. Hamoen, M. L. Yarmush, and J. R. Morgan. 2001. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 15:898-906.
3. Badet, C., and N. B. Thebaud. 2008. Ecology of lactobacilli in the oral cavity: a review of literature. Open Microbiol. J. 2:38-48.
4. Banerjee, P., G. J. Merkel, and A. K. Bhunia. 2009. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog. 1:8.
5. Burkholder, K. M., and A. K. Bhunia. 2009. Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG. Gut Pathog. 1:14.
6. Button, D., and N. L. Hemmings. 1976. Lipoteichoic acid from Bacillus licheniformis 6346 MH-1. Comparative studies on the lipid portion of the lipoteichoic acid and the membrane glycolipid. Biochemistry 15:989-995.
7. Cox, K. H., et al. 2009. Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS One 4:e5366.
8. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
9. Cywes Bentley, C., A. Hakansson, J. Christianson, and M. R. Wessels. 2005. Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling. Cell Microbiol. 7:945-955.
10. Daglia, M., et al. 2007. Antibacterial activity of red and white wine against oral streptococci. J. Agric. Food Chem. 55:5038-5042.
11. Datta, V., et al. 2005. Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol. Microbiol. 56:681-695.
12. DeVuono, J., and C. Panos. 1978. Effect of L-form Streptococcus pyogenes and of lipoteichoic acid on human cells in tissue culture. Infect. Immun. 22:255-265.
13. Draing, C., et al. 2008. Cytokine induction by Gram-positive bacteria. Immunobiology 213:285-296.
14. Elward, K., et al. 2005. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280:36342-36354.
15. Hafez, M. 2007. Interference between lactobacilli and group A Streptococcus pyogenes: an expansion to the concept of probiotics. N. Engl. J. Med. 17:262-284.
16. Jones, A., M. Georg, L. Maudsdotter, and A. B. Jonsson. 2009. Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J. Bacteriol. 191:3861-3868.
17. Klenk, M., et al. 2005. Global epithelial cell transcriptional responses reveal Streptococcus pyogenes Fas regulator activity association with bacterial aggressiveness. Cell Microbiol. 7:1237-1250. (Pubitemid 41179417)
18. Koll, P., et al. 2008. Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiol. Immunol. 23:139-147.
19. Leon, O., and C. Panos. 1983. Cytotoxicity and inhibition of normal collagen synthesis in mouse fibroblasts by lipoteichoic acid from Streptococcus pyogenes type 12. Infect. Immun. 40:785-794.
20. Leon, O., and C. Panos. 1985. Effect of streptococcal lipoteichoic acid on prolyl hydroxylase activity as related to collagen formation in mouse fibroblast monolayers. Infect. Immun. 50:745-752.
21. Leon, O., and C. Panos. 1987. An electron microscope study of kidney basement membrane changes in the mouse by lipoteichoic acid from Streptococcus pyogenes. Can. J. Microbiol. 33:709-717.
22. Leon, O., and C. Panos. 1990. Streptococcus pyogenes clinical isolates and lipoteichoic acid. Infect. Immun. 58:3779-3787.
23. Lovkvist, L., et al. 2008. CD46 contributes to the severity of group A streptococcal infection. Infect. Immun. 76:3951-3958.
24. Luca-Harari, B., et al. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47:1155-1165.
25. Mahtout, H., F. Chandad, J. M. Rojo, and D. Grenier. 2009. Porphyromonas gingivalis mediates the shedding and proteolysis of complement regulatory protein CD46 expressed by oral epithelial cells. Oral Microbiol. Immunol. 24:396-400.
26. Marouni, M. J., and S. Sela. 2004. Fate of Streptococcus pyogenes and epithelial cells following internalization. J. Med. Microbiol. 53:1-7.
27. Matsui, H., et al. 2009. CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection. Infect. Immun. 77:4806-4814.
28. Maurer, J. J., and S. J. Mattingly. 1991. Molecular analysis of lipoteichoic acid from Streptococcus agalactiae. J. Bacteriol. 173:487-494.
29. Michos, A., et al. 2006. Enhancement of streptolysin O activity and intrinsic cytotoxic effects of the group A streptococcal toxin, NAD-glycohydrolase. J. Biol. Chem. 281:8216-8223.
30. Molinari, G., and G. S. Chhatwal. 1998. Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J. Infect. Dis. 177:1600-1607.
31. Moorthy, G., M. R. Murali, and S. Niranjali Devaraj. 2010. Lactobacilli inhibit Shigella dysenteriae 1 induced pro-inflammatory response and cytotoxicity in host cells via impediment of Shigella-host interactions. Dig Liver Dis. 42:33-39.
32. Müller-Alouf, H., et al. 1994. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect. Immun. 62:4915-4921.
33. Nakagawa, I., M. Nakata, S. Kawabata, and S. Hamada. 2004. Transcriptome analysis and gene expression profiles of early apoptosis-related genes in Streptococcus pyogenes-infected epithelial cells. Cell Microbiol. 6:939-952. (Pubitemid 39255607)
34. Ofek, I., D. Zafriri, J. Goldhar, and B. I. Eisenstein. 1990. Inability of toxin inhibitors to neutralize enhanced toxicity caused by bacteria adherent to tissue culture cells. Infect. Immun. 58:3737-3742.
35. Plant, L., et al. 2006. Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis. Infect. Immun. 74:1360-1367.
36. Princivalli, M. S., et al. 2009. Lactobacillus rhamnosus GG inhibits invasion of cultured human respiratory cells by prtF1-positive macrolide-resistant group A streptococci. Lett. Appl. Microbiol. 48:368-372.
37. Quinn, R. W., and P. N. Lowry. 1967. Effect of Streptococcus pyogenes on tissue cells. J. Bacteriol. 93:1825-1831.
38. Roos, S., L. Engstrand, and H. Jonsson. 2005. Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int. J. Syst. Evol. Microbiol. 55:77-82.
39. Ross, P. W. 1971. Quantitative studies on the salivary flora. J. Clin. Pathol. 24:717-720.
40. Ryan, K. A., P. Daly, Y. Li, C. Hooton, and P. W. O'Toole. 2008. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J. Antimicrob. Chemother. 61:831-834.
41. Schrezenmeir, J., and M. de Vrese. 2001. Probiotics, prebiotics, and synbiotics - approaching a definition. Am. J. Clin. Nutr. 73:361S-364S.
42. Seo, H. S., R. T. Cartee, D. G. Pritchard, and M. H. Nahm. 2008. A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model. J. Bacteriol. 190:2379-2387.
43. Seo, H. S., and M. H. Nahm. 2009. Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but plateletactivating factor-acetylhydrolase degrades only lipoteichoic acids. Clin. Vaccine Immunol. 16:1187-1195.
44. Servin, A. L. 2004. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 28:405-440.
45. Sierig, G., C. Cywes, M. R. Wessels, and C. D. Ashbaugh. 2003. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group a streptococci. Infect. Immun. 71:446-455.
46. Silva, M., N. V. Jacobus, C. Deneke, and S. L. Gorbach. 1987. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31:1231-1233.
47. Simark-Mattsson, C., R. Jonsson, C. G. Emilson, and K. Roos. 2009. Final pH affects the interference capacity of naturally occurring oral Lactobacillus strains against mutans streptococci. Arch. Oral Biol. 54:602-607.
48. Simpson, W. A., J. B. Dale, and E. H. Beachey. 1982. Cytotoxicity of the glycolipid region of streptococcal lipoteichoic acid for cultures of human heart cells. J. Lab. Clin. Med. 99:118-126.
49. Simpson, W. A., and E. H. Beachey. 1983. Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect. Immun. 39:275-279.
50. Sjölinder, H., et al. 2008. The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model. Infect. Immun. 76:3959-3966.
51. Tomlinson, K., O. Leon, and C. Panos. 1983. Morphological changes and pathology of mouse glomeruli infected with a streptococcal L-form or exposed to lipoteichoic acid. Infect. Immun. 42:1144-1151.
52. Toon, P., P. E. Brown, and J. Baddiley. 1972. The lipid-teichoic acid complex in the cytoplasmic membrane of Streptococcus faecalis N.C.I.B. 8191. Biochem. J. 127:399-409.
53. Tsai, P. J., Y. S. Lin, C. F. Kuo, H. Y. Lei, and J. J. Wu. 1999. Group A Streptococcus induces apoptosis in human epithelial cells. Infect. Immun. 67:4334-4339.
54. Vielfort, K., H. Sjolinder, S. Roos, H. Jonsson, and H. Aro. 2008. Adherence of clinically isolated lactobacilli to human cervical cells in competition with Neisseria gonorrhoeae. Microbes Infect. 10:1325-1334.